Circulating Tumor DNA After Radical Cystectomy as a Marker of Minimal Residual Disease in Muscle-Invasive Bladder Cancer: A Literature Review

Clinical Genitourinary Cancer · Published 2026-06-08 · DOI 10.1016/j.clgc.2026.102596

Authors (3)

Patricia Rodríguez-Parras, Miguel Ángel Arrabal-Polo, Miguel Arrabal-Martín

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Rodríguez-Parras, P., Arrabal-Polo, M., Arrabal-Martín, M. (2026). Circulating Tumor DNA After Radical Cystectomy as a Marker of Minimal Residual Disease in Muscle-Invasive Bladder Cancer: A Literature Review. Clinical Genitourinary Cancer. https://doi.org/10.1016/j.clgc.2026.102596

Related articles

• CT-Measured Psoas Area Predicts Urinary Incontinence Trajectories and Persistence After Robotic Prostatectomy: A 12-Month Analysis Using the 1-Hour Pad Test · Clinical Genitourinary Cancer · 2026 · Same journal
• Age at Diagnosis and Postoperative Outcomes among Men Treated for Prostate Cancer in the U.S. Military Health System · Clinical Genitourinary Cancer · 2026 · Same journal
• Delayed Progression-Free Survival Benefit of Belzutifan Versus Everolimus in LITESPARK-005: A Reconstructed Time-to-Event Reanalysis · Clinical Genitourinary Cancer · 2026 · Same journal
• Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell Carcinoma · Clinical Genitourinary Cancer · 2026 · Same journal
• Evaluating Circulating DNA as a Prognostic Biomarker in Bladder Cancer Subtypes: A Preliminary Short Report · Clinical Genitourinary Cancer · 2026 · Same journal
• Oncologic Outcomes of Robot-Assisted Radical Cystectomy for Variant Histology Bladder Cancer: A Multi-institutional Propensity Score-Matched Analysis · Clinical Genitourinary Cancer · 2026 · Same journal
• Trophoblastic-Differentiated Urothelial Carcinoma: Real-World Sequencing and Clinical Implications · Clinical Genitourinary Cancer · 2026 · Same journal
• Teratoma-Specific Assay Design Enables Detection of Circulating Tumor DNA in Post-chemotherapy Residual Retroperitoneal Disease · Clinical Genitourinary Cancer · 2026 · Same journal
• Association Between Proto-Oncogene N-RAS Transcript Level and Overall Survival in Node-Negative Muscle-Invasive Bladder Cancer · Clinical Genitourinary Cancer · 2026 · Same journal
• Treatment Patterns and Survival Outcomes in a Real-World Cohort of Lutetium 177 Vipivotide Tetraxetan (LuPSMA)-Experienced Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) · Clinical Genitourinary Cancer · 2026 · Same journal